Evidence of Translocation of Oral Zn2+ Doped Magnetite Nanoparticles Across the Small Intestinal Wall of Mice and Deposition in Spleen: Unique Advantage in Biomedical Applications

2020 ◽  
Vol 3 (11) ◽  
pp. 7919-7929
Author(s):  
Rui Rong ◽  
Yun Zhang ◽  
Weihang Tan ◽  
Tingting Hu ◽  
Xiaoqin Wang ◽  
...  
2015 ◽  
Vol 380 ◽  
pp. 132-139 ◽  
Author(s):  
Erzsébet Illés ◽  
Etelka Tombácz ◽  
Márta Szekeres ◽  
Ildikó Y. Tóth ◽  
Ákos Szabó ◽  
...  

2021 ◽  
Vol 11 (22) ◽  
pp. 11075
Author(s):  
Angela Spoială ◽  
Cornelia-Ioana Ilie ◽  
Luminița Narcisa Crăciun ◽  
Denisa Ficai ◽  
Anton Ficai ◽  
...  

The interconnection of nanotechnology and medicine could lead to improved materials, offering a better quality of life and new opportunities for biomedical applications, moving from research to clinical applications. Magnetite nanoparticles are interesting magnetic nanomaterials because of the property-depending methods chosen for their synthesis. Magnetite nanoparticles can be coated with various materials, resulting in “core/shell” magnetic structures with tunable properties. To synthesize promising materials with promising implications for biomedical applications, the researchers functionalized magnetite nanoparticles with silica and, thanks to the presence of silanol groups, the functionality, biocompatibility, and hydrophilicity were improved. This review highlights the most important synthesis methods for silica-coated with magnetite nanoparticles. From the presented methods, the most used was the Stöber method; there are also other syntheses presented in the review, such as co-precipitation, sol-gel, thermal decomposition, and the hydrothermal method. The second part of the review presents the main applications of magnetite-silica core/shell nanostructures. Magnetite-silica core/shell nanostructures have promising biomedical applications in magnetic resonance imaging (MRI) as a contrast agent, hyperthermia, drug delivery systems, and selective cancer therapy but also in developing magnetic micro devices.


2007 ◽  
Vol 135 (1-2) ◽  
pp. 80-84
Author(s):  
Milena Bakrac ◽  
Branka Bonaci-Nikolic ◽  
Natasa Colovic ◽  
Sanja Simic-Ogrizovic ◽  
Miodrag Krstic ◽  
...  

Enteropathy associated T-cell lymphoma (EATCL) is a high grade, pleomorphic peripheral T-cell lymphoma with usually cytotoxic phenotype. This is a case report of three patients with EATCL. The first patient was 50 year-old woman with four year history of gluten sensitive enteropathy (GSE). Diagnosis of lymphoma was confirmed after the resection of the jejunum (small intestine obstruction). Pathohistological (PAS, Reticulin, Giemsa) and immunohistochemical (anti-LCA, anti-CD20, anti- CD45RO, anti-CD3) methods revealed the diagnosis of EATCL: CD45RO+, CD3+. After the third cycle of chemotherapy, the disease progressed with massive lung infiltration. Patient died due to complications of bone marrow aplasia. The second patient was 23 year-old woman with long earlier history of GSE. She presented with the acute renal failure. According to established diagnosis of tubulointerstitial nephritis, she was treated with pulse doses of steroid therapy. After temporary improvement, she had dissemination of the disease. On MRI, small intestinal wall was thickened, and abdominal lymph nodes were enlarged with extraluminal compression of common bile duct. Laparotomy with mesenterial lymph node biopsy and consecutive pathohistological and immunohistochemical analyses revealed the diagnosis of EATCL. The patient received chemotherapy, but she died with signs of pulmonary embolization. The third patient was 53 year-old woman without previous history of GSE. Diagnosis of EATCL was revealed after the resection of jejunum because of small intestinal obstruction. She received two cycles of chemotherapy, but she died with signs of disease progression. IgA antiendomysial antibodies were detected in the serum of all patients. The overall survival of patients was 7 months. The possibility of lymphoma rising in patients with clinical progression of GSE despite gluten free diet must be kept in mind.


RSC Advances ◽  
2020 ◽  
Vol 10 (68) ◽  
pp. 41807-41815
Author(s):  
Lizbet León Félix ◽  
Marco Antonio Rodriguez Martínez ◽  
David Gregorio Pacheco Salazar ◽  
José Antonio Huamani Coaquira

Magnetic nanoparticles (NPs) are especially interesting for several biomedical applications due to their chemical surface, especially for targeted cancer imaging and therapeutics.


Author(s):  
S. Gustafsson ◽  
A. Fornara ◽  
F. Ye ◽  
K. Petersson ◽  
C. Johansson ◽  
...  

Nanomaterials ◽  
2020 ◽  
Vol 10 (8) ◽  
pp. 1500
Author(s):  
Laura Madalina Cursaru ◽  
Roxana Mioara Piticescu ◽  
Dumitru Valentin Dragut ◽  
Robert Morel ◽  
Caroline Thébault ◽  
...  

Iron oxide nanoparticles have received remarkable attention in different applications. For biomedical applications, they need to possess suitable core size, acceptable hydrodynamic diameter, high saturation magnetization, and reduced toxicity. Our aim is to control the synthesis parameters of nanostructured iron oxides in order to obtain magnetite nanoparticles in a single step, in environmentally friendly conditions, under inert gas atmosphere. The physical–chemical, structural, magnetic, and biocompatible properties of magnetite prepared by hydrothermal method in different temperature and pressure conditions have been explored. Magnetite formation has been proved by Fourier-transform infrared spectroscopy and X-ray diffraction characterization. It has been found that crystallite size increases with pressure and temperature increase, while hydrodynamic diameter is influenced by temperature. Magnetic measurements indicated that the magnetic core of particles synthesized at high temperature is larger, in accordance with the crystallite size analysis. Particles synthesized at 100 °C have nearly identical magnetic moments, at 20 × 103 μB, corresponding to magnetic cores of 10–11 nm, while the particles synthesized at 200 °C show slightly higher magnetic moments (25 × 103 μB) and larger magnetic cores (13 nm). Viability test results revealed that the particles show only minor intrinsic toxicity, meaning that these particles could be suited for biomedical applications.


2014 ◽  
Vol 49 (24) ◽  
pp. 8487-8497 ◽  
Author(s):  
Dena Dorniani ◽  
Aminu Umar Kura ◽  
Mohd Zobir Bin Hussein ◽  
Sharida Fakurazi ◽  
Abdul Halim Shaari ◽  
...  

1969 ◽  
Vol 17 (5) ◽  
pp. 341-347 ◽  
Author(s):  
CHRISTER NORDSTRÖM ◽  
OTAKAR KOLDOVSKÝ ◽  
ARNE DAHLQVIST

By horizontal sectioning of fresh frozen pieces of rat intestinal wall different parts of the villi and crypts were isolated. The sections were collected in groups, homogenized and used for enzyme analyses. Single sections for histologic examination were taken before and after each collection. A quantitative comparison of the distribution of the two intestinal β-galactosidases, EC 3.2.1.23 (neutral and acid β-galactosidase), and the acid phosphatase, EC 3.1.3.2, in jejunum and ileum of adult and suckling (12 days old) rats was performed. The neutral β-galactosidase, which corresponds to the enzyme usually called lactase, was always present along the villi with the highest activities in the apical halves of the villi. This distribution profile is typical for digestion enzymes. The acid β-galactosidase, which is chiefly a heterogalactosidase, and acid phosphatase were found to have a rather flat distribution profile with about the same activities along the villi and in the crypts. The only exception was the ileum of suckling rat, in which especially the acid β-galactosidase showed higher activity in the villi and decreased toward the crypts. The results support the concept that the neutral β-galactosidase is responsible for the digestion of dietary lactose, while the acid β-galactosidase seems to have a different functional significance. That this enzyme is distributed in parallel with the acid phosphatase is consistent with the suggestion that the acid β-galactosidase may be a lysosomal enzyme.


2013 ◽  
Vol 328 ◽  
pp. 91-95 ◽  
Author(s):  
Elham Cheraghipour ◽  
A.M. Tamaddon ◽  
S. Javadpour ◽  
I.J. Bruce

Sign in / Sign up

Export Citation Format

Share Document